ACAD
36.32
+0.49
+1.37%
AEMD
0.967
-0.013
-1.2857%
APRI
1.81
-0.01
-0.55%
ARNA
27.29
-0.02
-0.07%
ATEC
4.18
+0.06
+1.46%
CNAT
5.104
+0.094
+1.8802%
CRXM
0.137
+0.034
+32.9767%
CYTX
0.485
+0.02
+4.301%
DXCM
44.9
-0.08
-0.18%
GNMK
7.86
+0.02
+0.26%
HALO
17.84
+0.07
+0.39%
ILMN
209.63
+4.45
+2.17%
INNV
0.087
0.00
0.00%
INO
6.3
+0.05
+0.80%
ISCO
1.65
+0.11
+7.14%
ISIS
57.56
0.00
0.00%
LGND
144.7
+1.35
+0.94%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
-0.03
-4.03%
MEIP
2.63
+0.01
+0.38%
MNOV
6.15
-0.04
-0.65%
MRTX
15.832
+0.282
+1.8109%
MSTX
0.13
-0.01
0.00%
NBIX
59.406
+0.446
+0.756%
NUVA
55.32
+0.75
+1.37%
ONCS
1.26
-0.03
-2.33%
ONVO
1.629
+0.229
+16.3857%
OREX
1.79
-0.03
-1.65%
OTIC
3.425
-0.05
-1.439%
QDEL
41.65
-0.3
-0.72%
RCPT
231.96
0.00
0.00%
RGLS
1.22
-0.03
-2.40%
RMD
79.29
+0.5
+0.63%
SCIE
0
0.00
0.00%
SPHS
2.321
+0.081
+3.616%
SRNE
2.73
+0.23
+9.20%
TROV
0.807
-0.002
-0.2472%
VICL
2.34
-0.04
-1.68%
VOLC
18
0.00
0.00%
ZGNX
40
+0.35
+0.88%
ACAD
36.32
+0.49
+1.37%
AEMD
0.967
-0.013
-1.2857%
APRI
1.81
-0.01
-0.55%
ARNA
27.29
-0.02
-0.07%
ATEC
4.18
+0.06
+1.46%
CNAT
5.104
+0.094
+1.8802%
CRXM
0.137
+0.034
+32.9767%
CYTX
0.485
+0.02
+4.301%
DXCM
44.9
-0.08
-0.18%
GNMK
7.86
+0.02
+0.26%
HALO
17.84
+0.07
+0.39%
ILMN
209.63
+4.45
+2.17%
INNV
0.087
0.00
0.00%
INO
6.3
+0.05
+0.80%
ISCO
1.65
+0.11
+7.14%
ISIS
57.56
0.00
0.00%
LGND
144.7
+1.35
+0.94%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
-0.03
-4.03%
MEIP
2.63
+0.01
+0.38%
MNOV
6.15
-0.04
-0.65%
MRTX
15.832
+0.282
+1.8109%
MSTX
0.13
-0.01
0.00%
NBIX
59.406
+0.446
+0.756%
NUVA
55.32
+0.75
+1.37%
ONCS
1.26
-0.03
-2.33%
ONVO
1.629
+0.229
+16.3857%
OREX
1.79
-0.03
-1.65%
OTIC
3.425
-0.05
-1.439%
QDEL
41.65
-0.3
-0.72%
RCPT
231.96
0.00
0.00%
RGLS
1.22
-0.03
-2.40%
RMD
79.29
+0.5
+0.63%
SCIE
0
0.00
0.00%
SPHS
2.321
+0.081
+3.616%
SRNE
2.73
+0.23
+9.20%
TROV
0.807
-0.002
-0.2472%
VICL
2.34
-0.04
-1.68%
VOLC
18
0.00
0.00%
ZGNX
40
+0.35
+0.88%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.

Be Sociable, Share!